Stuart Walter Peltz - Jan 10, 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Stock symbol
PTCT
Transactions as of
Jan 10, 2023
Transactions value $
-$151,805
Form type
4
Date filed
1/12/2023, 03:34 PM
Previous filing
Jan 11, 2023
Next filing
Jan 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale -$52.7K -1.23K -0.72% $42.93 170K Jan 10, 2023 Direct F1
transaction PTCT Common Stock Sale -$24.5K -571 -1.01% $42.93 56K Jan 10, 2023 By Spouse F2
transaction PTCT Common Stock Sale -$52.7K -1.19K -0.7% $44.36 169K Jan 11, 2023 Direct F1
transaction PTCT Common Stock Sale -$21.8K -492 -0.88% $44.36 55.5K Jan 11, 2023 By Spouse F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 11,000RSUs from a January 7, 2022 grant of 44,000 RSUs.
F2 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 4,200 RSUs from a January 7, 2022 grant of 16,800 RSUs.